Novo Nordisk’s (NVO) etavopivat was granted FDA orphan designation for treatment of thalassemias, according to a post on the agency’s ...

Health Minister Satyakumar Yadav has said the government is committed to providing comprehensive support to thalassemia ...

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

Will consider increasing pension and extending it to all thalassemia patients, says Andhra Pradesh Health Minister Satya ...

We all know the UConn women’s program is one of the most decorated and accomplished in sports history, and the journey to ...

Union Minister Nitin Gadkari commended the Smrutishesh Madhukarrao Tamgadge Charitable Trust, led by IPS officer Sandeep ...

India is known as the “Thalassemia capital of the world.” It has the highest number of patients with thalassemia major in the world. India has around 50 million (5 crore) carriers of the ß ...

Equities research analysts at StockNews.com initiated coverage on shares of bluebird bio (NASDAQ:BLUE – Get Free Report) in a ...

National Workshop on ‘Sickle Cell and Thalassemia Elimination: Best Practices and Scalable Strategies’ was successfully held ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...